Irene Lou1,2, Todd B Chennell2, Sarah C Schaefer1, Herbert Chen1,3, Rebecca S Sippel1, Courtney Balentine1,3, David F Schneider1, Jacob Moalem4. 1. Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, Madison, WI, USA. 2. Department of Surgery, University of Rochester, Rochester, NY, USA. 3. Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Department of Surgery, University of Rochester, Rochester, NY, USA. Jacob_Moalem@URMC.Rochester.edu.
Abstract
BACKGROUND: Thyroidectomy and parathyroidectomy are the most commonly performed endocrine operations, and are increasingly being completed on a same-day basis; however, few data exist regarding the outpatient postoperative pain requirement of these patients. We aimed to describe the outpatient narcotic medication needs for patients undergoing thyroid and parathyroid surgery, and to identify predictors of higher requirement. METHOD: We examined patients undergoing thyroid and parathyroid surgery at two large academic institutions from 1 January-30 May 2014. Prospective data were collected on pain scores and the oral morphine equivalents (OMEQs) taken by these patients by their postoperative visit. RESULTS: Overall, 313 adult patients underwent thyroidectomy or parathyroidectomy during the study period; 83% of patients took ten or fewer OMEQs, and 93% took 20 or fewer OMEQs. Patients who took more than ten OMEQs were younger (p < 0.001) and reported significantly higher overall mean pain scores at their postoperative visit (p < 0.001) than patients who took fewer than ten OMEQs. A multivariate model was constructed on pre- and intraoperative factors that may predict use of more than ten OMEQs postoperatively. Age <45 years (p = 0.002), previous narcotic use (p = 0.037), and whether parathyroid or thyroid surgery was performed (p = 0.003) independently predicted the use of more than ten OMEQs after surgery. A subgroup analysis was then performed on thyroidectomy-only patients. CONCLUSION: Overall, 93% of patients undergoing thyroidectomy and parathyroidectomy require 20 or fewer OMEQs by their postoperative visit. We therefore recommend these patients be discharged with 20 OMEQs, both to minimize waste and increase patient safety.
BACKGROUND: Thyroidectomy and parathyroidectomy are the most commonly performed endocrine operations, and are increasingly being completed on a same-day basis; however, few data exist regarding the outpatientpostoperative pain requirement of these patients. We aimed to describe the outpatient narcotic medication needs for patients undergoing thyroid and parathyroid surgery, and to identify predictors of higher requirement. METHOD: We examined patients undergoing thyroid and parathyroid surgery at two large academic institutions from 1 January-30 May 2014. Prospective data were collected on pain scores and the oral morphine equivalents (OMEQs) taken by these patients by their postoperative visit. RESULTS: Overall, 313 adult patients underwent thyroidectomy or parathyroidectomy during the study period; 83% of patients took ten or fewer OMEQs, and 93% took 20 or fewer OMEQs. Patients who took more than ten OMEQs were younger (p < 0.001) and reported significantly higher overall mean pain scores at their postoperative visit (p < 0.001) than patients who took fewer than ten OMEQs. A multivariate model was constructed on pre- and intraoperative factors that may predict use of more than ten OMEQs postoperatively. Age <45 years (p = 0.002), previous narcotic use (p = 0.037), and whether parathyroid or thyroid surgery was performed (p = 0.003) independently predicted the use of more than ten OMEQs after surgery. A subgroup analysis was then performed on thyroidectomy-only patients. CONCLUSION: Overall, 93% of patients undergoing thyroidectomy and parathyroidectomy require 20 or fewer OMEQs by their postoperative visit. We therefore recommend these patients be discharged with 20 OMEQs, both to minimize waste and increase patient safety.
Authors: David J Terris; Samuel Snyder; Denise Carneiro-Pla; William B Inabnet; Emad Kandil; Lisa Orloff; Maisie Shindo; Ralph P Tufano; R Michael Tuttle; Mark Urken; Michael W Yeh Journal: Thyroid Date: 2013-09-14 Impact factor: 6.568
Authors: Ammara A Watkins; Timothy V Johnson; Adam B Shrewsberry; Paymon Nourparvar; Tarik Madni; Colyn J Watkins; Paul L Feingold; David A Kooby; Shishir K Maithel; Charles A Staley; Viraj A Master Journal: J Am Coll Surg Date: 2014-05-23 Impact factor: 6.113
Authors: Aron J Hall; Joseph E Logan; Robin L Toblin; James A Kaplan; James C Kraner; Danae Bixler; Alex E Crosby; Leonard J Paulozzi Journal: JAMA Date: 2008-12-10 Impact factor: 56.272
Authors: Mayo H Fujii; Ashley C Hodges; Ruby L Russell; Kristin Roensch; Bruce Beynnon; Thomas P Ahern; Peter Holoch; Jesse S Moore; S Elizabeth Ames; Charles D MacLean Journal: J Am Coll Surg Date: 2018-02-28 Impact factor: 6.113
Authors: Jennifer P March; James Y Lim; Katherine L Manzione; Michelle Buncke; Maisie L Shindo Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-06-01 Impact factor: 8.961
Authors: Alexander W Murphey; Suqrat Munawar; Shaun A Nguyen; Ted A Meyer; Ashli K O'Rourke Journal: World J Otorhinolaryngol Head Neck Surg Date: 2019-05-09